Alemtuzumab induction therapy in highly sensitized kidney transplant recipients.
Year: 2011
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: PubMed
Language: English
Subfield: Transplantation
Field: Medicine
Domain: Health Sciences
Keywords: alemtuzumab, kidney transplantation, induction therapy, antithymocyte globulin, highly sensitized patients, panel reactive antibody, graft survival, acute rejection, infection, immunosuppression, tacrolimus, mycophenolate mofetil, CD52, graft failure, post-transplant mortality, neutropenia, acute myocardial infarction
Open Access status: closed
OpenAlex ID: W8064881
